Old Web
English
Sign In
Acemap
>
authorDetail
>
Nadya Lisovoder
Nadya Lisovoder
Immunology
Medicine
Virology
Immunotherapy
Diabetes mellitus
3
Papers
63
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.
2015
Journal of Viral Hepatitis
Waldemar Halota
P. Ferenci
Dorota Kozielewicz
Dorota Dybowska
Nadya Lisovoder
Sarit Samira
I. Shalit
Ronald J. Ellis
Yaron Ilan
Show All
Source
Cite
Save
Citations (18)
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.
2015
Journal of Clinical Immunology
Gadi Lalazar
Meir Mizrahi
Ilit Turgeman
Tomer Adar
Ami Ben Ya’acov
Yehudit Shabat
Assy Nimer
Nila Hemed
Lidya Zolotarovya
Yoav Lichtenstein
Nadya Lisovoder
Sarit Samira
Itamar Shalit
Ronald J. Ellis
Yaron Ilan
Show All
Source
Cite
Save
Citations (44)
1202 ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS SAFE, PROMOTES REGULATORY T CELLS, AND DECREASES VIRAL LOAD AND LIVER ENZYME LEVELS: RESULTS OF A PHASE-2a PLACEBO-CONTROLLED TRIAL
2013
Journal of Hepatology
Waldemar Halota
P. Ferenzi
Dorota Kozielewicz
Dorota Dybowska
Nadya Lisovoder
Sarit Samira
I. Shalit
Ronald J. Ellis
Yaron Ilan
Show All
Source
Cite
Save
Citations (1)
1